Clinical Trial Update: Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update of a Phase 1/2 study evaluating the combination of clofarabine and cytarabine in older patients with acute myeloid leukemia or high-risk m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clolar (Clofarabine)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-11